Activity-Based Probes for Tumour-Associated Transglutaminase 2: From Potent and Selective Inhibitors to Radiotracers

The talk is covering the efforts of our group in the development of inhibitor-based radiotracers for the imaging of tumour-associated transglutaminase 2 (TGase 2). Major emphasis will be put on interesting structure-activity relationships of N⁶-acryloyllysine-derived inhibitors. In addition, general principles for targeting of TGase 2 by irreversible inhibitors will be highlighted. Labelling of these compounds with fluorine-18 and initial results towards their radiopharmacological evaluation will be presented.